Potassium%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCl) is an electrolyte replacement used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing * **Oral:** * Prevention: 20 mEq (1.5 g) to 40 mEq (3 g) daily, divided into 1-2 doses. * Treatment: 40 mEq (3 g) to 100 mEq (7.5 g) daily, divided into 2-4 doses. Maximum dose is typically 200 mEq (15 g) per day. * *Note: Specific dosing depends on the degree of hypokalemia and electrolyte balance; local protocols should be consulted.* * **Intravenous (IV):** * Administer slowly and diluted to prevent phlebitis and hyperkalemia. * **Mild to moderate hypokalemia:** 10 mEq to 20 mEq over 1-2 hours. * **Severe hypokalemia or cardiac arrhythmias:** 20 mEq to 40 mEq per hour, not to exceed 10 mEq/hour through a peripheral IV. Maximum infusion rate for peripheral IV is 10 mEq/hour. Central venous access may allow higher rates, but typically not exceeding 20 mEq/hour. Maximum total daily dose is generally 200 mEq (15 g). * *Note: IV KCl administration is a critical care intervention. Dosing, rate, and concentration are highly dependent on patient status, serum potassium levels, and cardiac monitoring. Strict adherence to institutional guidelines and physician orders is mandatory.* ## Pediatric Dosing * **Oral:** * Prevention: 1 mEq/kg/day to 2 mEq/kg/day, not to exceed 3 g/day. * Treatment: 2 mEq/kg/day to 5 mEq/kg/day, divided into 2-4 doses, not to exceed 7.5 g/day. * *Note: Specific dosing depends on age, weight, degree of hypokalemia, and renal function.* * **Intravenous (IV):** * Dosing varies significantly based on age and serum potassium. * Typical maintenance: 1 mEq/kg/day to 3 mEq/kg/day. * Correction: May require higher doses, with careful titration and cardiac monitoring. Maximum infusion rate generally 0.5 mEq/kg/hour or 20 mEq/hour, whichever is less. * Concentrations should not exceed 40 mEq/L in peripheral lines and 60 mEq/L in central lines to minimize phlebitis. * *Note: Pediatric IV KCl administration requires extreme caution, especially in neonates and infants. Continuous cardiac monitoring and frequent serum potassium checks are essential. Local pediatric protocols must be followed.* ## Dose Adjustments * **Renal Impairment:** Use with caution. Reduce dose and monitor potassium levels closely. Severe renal impairment may preclude use. ## Contraindications * Hyperkalemia. * Conditions causing elevated potassium levels (e.g., severe renal impairment, untreated Addison's disease, acute dehydration, extensive tissue breakdown). * Certain medications that increase potassium (e.g., potassium-sparing diuretics, ACE inhibitors, ARBs, NSAIDs, certain immunosuppressants). ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal discomfort, flatulence. * **Serious:** Hyperkalemia (symptoms include muscle weakness, paresthesias, paralysis, cardiac arrhythmias, cardiac arrest), gastrointestinal ulceration or bleeding (especially with sustained-release formulations or rapid ingestion). ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride), ACE inhibitors (e.g., lisinopril), ARBs (e.g., losartan), NSAIDs (e.g., ibuprofen), heparin, certain immunosuppressants (e.g., cyclosporine, tacrolimus):** Increased risk of hyperkalemia. Monitor potassium levels closely. * **Aldosterone antagonists (e.g., eplerenone):** Increased risk of hyperkalemia. * **Succinylcholine:** May increase serum potassium levels. * **Salt substitutes:** Contain high amounts of potassium chloride and can lead to accidental overdose. ## Monitoring * Serum potassium levels (frequency depends on route of administration, dose, and patient condition). * Renal function (BUN, creatinine). * ECG (especially with IV administration or risk of hyperkalemia). * Signs and symptoms of hypokalemia or hyperkalemia. * For oral liquid formulations, monitor for gastrointestinal tolerance. ## Clinical Pearls * Always dilute IV potassium chloride. Never administer as a direct IV push. * Oral potassium chloride should be taken with meals or fluids to minimize gastrointestinal irritation. * Sustained-release oral formulations are associated with a higher risk of gastrointestinal ulceration and should be used cautiously in patients with pre-existing GI disease. * Consider the total potassium load from all sources, including diet and other medications. *** **Disclaimer:** This information is intended for healthcare professionals and should not be considered a substitute for professional medical advice. Always consult the most current prescribing information and local protocols before making clinical decisions.